Sciensus achieves 95% patient satisfaction and record NPS
At Sciensus, delivering life-changing therapies is more than a service — it’s a commitment to the people behind every prescription. In our latest annual Patient Satisfaction Survey, an overwhelming 95% of respondents reported being satisfied with the support and services we provide — a testament to the dedication of our clinical, nursing, logistics and digital care teams across Europe.
This year’s Net Promoter Score (NPS) of 64, up from 57 in 2024, reflects a consistent and growing confidence in the way we care for patients and our commitment to continuous improvement. It confirms our belief that putting patients at the centre of every decision drives better experiences, stronger outcomes and greater impact for the life sciences partners we support.
Touchpoints that matter most
Patients rated us highly across key areas of care, including:
- Patient Services: 87%+ satisfaction across all service touchpoints
- Intouch App (Information & Communication): 89% satisfaction, confirming the value of digital support in enhancing patient experience
- Nursing & Clinical Support: Over 91% satisfaction — a strong endorsement of our clinical homecare teams
- Delivery Services: Over 88% satisfaction, highlighting our consistent, reliable logistics
I’m very happy with my care plan and the way it’s delivered. The nurses are all very kind, approachable, and caring. I’m very satisfied with the service provided.
Patient
Commitment reinforced by innovation
Our digital solutions continue to enhance the patient’s experience, with tools that help people manage their treatment journey, communicate with their care teams, and feel empowered in their own health. This integration of technology and human care ensures patients remain informed, engaged and supported every step of the way.
A powerful signal to our partners
These results not only reflect patient satisfaction — they demonstrate our capability as a trusted partner to biopharma and healthcare systems looking to deliver better outcomes at scale. From decentralised trials and early access programmes to clinical homecare and real-world data collection, Sciensus enables seamless patient engagement and therapy delivery across the product lifecycle.
About Sciensus
Sciensus is the UK’s leading provider of complex clinical care at home. For over 30 years, we have partnered with the NHS to deliver specialist medicines, clinical nursing and patient support to people living with cancer, rare diseases and complex long-term conditions – supporting more than 300,000 patients a year across 180+ NHS trusts.
Beyond the UK, Sciensus helps pharmaceutical and biotech companies reach patients across Europe, managing the regulatory, logistics and patient support complexity of launching medicines in multiple markets.
